Adagio Therapeutics Inc
Biotechnology
Healthcare
ADGI
108 M shares
NASDAQ US
traded
14 Nov 2022
listed
yes
open
3.55
52 week high
47.04
high
3.58
52 week low
2.54
low
3.46
growth
-86.15 %
previous Close
3.60
P/E ratio
market cap
423 M
div yield
0
usd
Jun 2022
qoq
revenue
0.00 %
net incoming
-50.99 M
49.35 %
eps
0.00 %
49.46 %
eps surprise
17.54 %
net profit margin
-5099000000.00 %
0.00 %
operating incoming
-51.75 M
48.63 %
net change in cash
-57.34 M
-473.12 %
cash on hand
475 M
-10.77 %
cost of revenue
0.00 %
top top